A growing interest has emerged around GLP-1 medications, particularly copyright, for their ability to address diabetes and promote weight loss. These innovative therapies, initially developed for diabetes care, have demonstrated remarkable results in helping individuals attain their health goals. While copyright are related in their mechanism of ac